共 18 条
[1]
Global cancer statistics, 2012[J] . Lindsey A. Torre,Freddie Bray,Rebecca L. Siegel,Jacques Ferlay,Joannie Lortet‐Tieulent,Ahmedin Jemal.CA: A Cancer Journal for Clinicians . 2015 (2)
[2]
Comparative analysis of innate immune system function in metastatic breast, colorectal, and prostate cancer patients with circulating tumor cells[J] . Mark F. Santos,Venkat K.R. Mannam,Barbara S. Craft,Louis V. Puneky,Natale T. Sheehan,Robert E. Lewis,Julius M. Cruse.Experimental and Molecular Pathology . 2014 (3)
[3]
Effects of cancer on platelets[J] . N. van Es,A. Sturk,S. Middeldorp,R. Nieuwland.Seminars in Oncology . 2014
[6]
Survivin-3B promotes chemoresistance and immune escape by inhibiting caspase-8 and-6 in cancer cells
[J].
ONCOIMMUNOLOGY,
2013, 2 (11)
[7]
Corrigendum to the article entitled “Circulating tumor cells (CTCs) from metastatic breast cancer patients linked to decreased immune function and response to treatment”[Exp. Mol. Pathol. 95/2 (2013) 174–179][J] . Taryn Green.Experimental and Molecular Pathology . 2013
[8]
Cross-talk between myeloid-derived suppressor cells (MDSC), macrophages, and dendritic cells enhances tumor-induced immune suppression[J] . Suzanne Ostrand-Rosenberg,Pratima Sinha,Daniel W. Beury,Virginia K. Clements.Seminars in Cancer Biology . 2012 (4)
[9]
Circulating tumour cells, their role in metastasis and their clinical utility in lung cancer[J] . John D. O’Flaherty,Steven Gray,Derek Richard,Dean Fennell,John J. O’Leary,Fiona H. Blackhall,Kenneth J. O’Byrne.Lung Cancer . 2012 (1)
[10]
Hallmarks of Cancer: The Next Generation[J] . Douglas Hanahan,Robert A. Weinberg.Cell . 2011 (5)